Tofranil
Active ingredient: Imipramine
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Imipramine, the active ingredient of Tofranil, is a tricyclic antidepressant used for depressive illness and selected specialist indications. Tofranil is prescribed when changes in serotonin and noradrenaline signalling may support mood regulation or symptom control.
Product information
Imipramine, the active ingredient of Tofranil, is a tricyclic antidepressant used for depressive illness and selected specialist indications. Tofranil is prescribed when changes in serotonin and noradrenaline signalling may support mood regulation or symptom control. Its dose is chosen individually according to age, other medicines, health conditions, and treatment response.
How it affects the body
Imipramine affects the reuptake of serotonin and noradrenaline in nerve cells. By slowing their reuptake, it increases the availability of these neurotransmitters in the spaces between neurons. This action supports changes in signalling linked with mood, anxiety, sleep, and pain perception.
Serotonin contributes to mood, anxiety, sleep, appetite, and emotional regulation. Noradrenaline supports alertness, attention, motivation, and the response to stress. Tofranil changes both signalling systems.
Ingredients
Tofranil contains imipramine, a tricyclic antidepressant that acts on the central nervous system. It is used in adults with depressive illness and may have specialist applications in anxiety disorders or childhood nocturnal enuresis, depending on the clinical assessment and local prescribing information.
Tricyclic antidepressants are an established medicine class. They can help with mood symptoms, yet they often produce more anticholinergic, sedating, and cardiovascular effects than some newer antidepressants. The balance between expected benefit and risk needs individual assessment.
Imipramine Active Ingredient
Imipramine affects the reuptake of serotonin and noradrenaline in nerve cells. By slowing their reuptake, it increases the availability of these neurotransmitters in the spaces between neurons. This action supports changes in signalling linked with mood, anxiety, sleep, and pain perception.
The chemical effect begins before the clinical response. Mood improvement usually develops gradually, and early sedation or dry mouth does not mean the antidepressant benefit has fully appeared. The FDA prescribing information describes imipramine as a medicine requiring careful dose selection and monitoring because of its nervous-system and cardiovascular effects [1].
Serotonin and Noradrenaline Signalling
Serotonin contributes to mood, anxiety, sleep, appetite, and emotional regulation. Noradrenaline supports alertness, attention, motivation, and the response to stress. Tofranil changes both signalling systems, so its effects can include improved mood alongside sleepiness, dizziness, constipation, or changes in heart rate.
Dosage and administration
The dose of Tofranil is decided individually. Age, diagnosis, other medicines, liver function, heart health, previous treatment response, and tolerability all influence the prescription.
- Take Tofranil exactly as prescribed.
- Swallow the pills with water unless a prescriber gives different instructions.
- Do not increase the dose because improvement seems slow.
- Do not take an extra pill to compensate for a missed dose.
- If a dose is missed, take the next dose at the scheduled time unless a clinician gives different advice.
- If too much has been taken, seek urgent medical help or contact a poison service immediately.
- Do not stop regular treatment suddenly, because withdrawal-like symptoms and return of depression may follow.
- When sedation is prominent, an evening schedule may be chosen, but timing changes require prescriber approval.
Dose Selection and Treatment Timing
Older adults, children, and people with heart disease or liver disease often need more cautious treatment. A prescriber may begin with a lower amount and adjust it gradually according to response and adverse effects.
The antidepressant response can take time. Early treatment may bring dry mouth, sleepiness, blurred vision, or dizziness before mood symptoms improve. That pattern does not justify self-directed dose changes.
Missed Dose and Overdose Actions
Never double the next dose after a missed tablet. Taking extra imipramine can cause severe drowsiness, confusion, seizures, low blood pressure, dangerous heart-rhythm changes, or loss of consciousness.
Overdose symptoms may develop quickly. Emergency care is needed after a suspected overdose, even if the person initially feels well.
When not to use it
Tofranil may be unsuitable or require specialist assessment in people with:
- A recent heart attack or significant heart disease
- Known heart-rhythm abnormalities
- A personal or family history of sudden cardiac death
- Seizures or a condition that lowers the seizure threshold
- Bipolar disorder or previous manic episodes
- Narrow-angle glaucoma
- Urinary retention or significant prostate-related obstruction
- Severe liver disease
- Severe sensitivity to tricyclic antidepressants
- Suicidal thoughts or rapidly worsening depression
Tofranil may be inappropriate if you have a serious rhythm problem, recent heart attack, untreated urinary retention, narrow-angle glaucoma, a severe reaction to tricyclic antidepressants, or a current need for an interacting monoamine oxidase inhibitor.
When this is not for you
Tofranil is not suitable for everyone. A prescriber needs a focused medical history before treatment, especially when another medicine affects the heart, brain, mood, or blood pressure.
A history of bipolar disorder matters because an antidepressant can contribute to mood switching in susceptible patients. A seizure history matters because imipramine may lower the seizure threshold.
Patients, relatives, and caregivers should watch for new suicidal thoughts, severe agitation, unusual energy, reckless behaviour, hallucinations, or a sudden reduction in the need for sleep. Urgent help is needed when suicidal intent or immediate danger is present.
Pregnancy and breastfeeding require an individual risk assessment. Do not stop an established antidepressant abruptly after discovering a pregnancy. The prescriber and maternal-care team can weigh untreated illness against medicine exposure.
Older adults may be more sensitive to confusion, constipation, urinary difficulty, low blood pressure, falls, and heart-rhythm effects. Monitoring may include blood pressure, mental state, treatment response, and, when indicated, an electrocardiogram.
Possible side effects
Tofranil can cause anticholinergic, nervous-system, gastrointestinal, cardiovascular, and allergic effects. The likelihood and intensity depend on the dose, age, other medicines, and individual sensitivity.
Common or clinically significant effects include:
- Dry mouth
- Constipation or diarrhoea
- Dizziness or light-headedness
- Headache
- Sleepiness or impaired concentration
- Blurred vision
- Sweating
- Nausea
- Changes in blood pressure
- Tinnitus, meaning ringing or other noise in the ears
- Difficulty passing urine
- Fast, irregular, or forceful heartbeat
Dry mouth may improve with frequent sips of water or sugar-free chewing gum. Avoid excessive sugary drinks because they increase dental risk without correcting the medicine’s anticholinergic effect. Persistent constipation deserves medical advice rather than prolonged self-treatment with laxatives.
Dizziness can be worse when rising from a chair or bed. Move slowly, use support if needed, and take extra care around stairs. Older adults may face a greater risk of falls.
Driving should wait until the response to Tofranil is known. Alcohol, sedatives, and sleep deprivation can add to impaired coordination.
Seek urgent medical care for fainting, chest pain, severe palpitations, seizures, severe confusion, inability to pass urine, severe allergic swelling, difficulty breathing, or suicidal intent. Serious rhythm disturbances can occur without dramatic warning symptoms.
Tinnitus, a sustained rise in blood pressure, or severe headache also deserves prompt clinical review. High blood pressure is only one possible cardiovascular problem; low blood pressure on standing and abnormal heart rhythms can also occur.
Therapeutic indications
Tofranil has several established or specialist clinical uses. The indication, treatment duration, and monitoring plan depend on the patient’s age, diagnosis, medical history, and response.
| Clinical situation | Role of imipramine | Main treatment aim |
|---|---|---|
| Depressive illness | Tricyclic antidepressant treatment | Improve mood, motivation, sleep, and daily function |
| Selected anxiety disorders | Specialist-prescribed option | Reduce persistent anxiety symptoms |
| Childhood nocturnal enuresis | Specialist use after assessment | Reduce night-time bed-wetting |
Depression Treatment
For depression, Tofranil may be used when a tricyclic antidepressant is clinically appropriate. Treatment aims include reducing low mood, loss of interest, poor motivation, sleep disturbance, and changes in appetite or concentration. Benefit is gradual and varies between individuals.
Worsening suicidal thoughts, severe agitation, unusual impulsivity, or major behavioural changes require urgent medical attention. These symptoms can occur during depressive illness or during changes in antidepressant treatment. NICE guidance on depression in adults stresses active monitoring of mental state and treatment response, with special attention to suicide risk [2].
Anxiety Disorder Treatment
Imipramine may be considered for selected anxiety disorders, but it is not a universal treatment for every form of anxiety. A prescriber may assess panic symptoms, coexisting depression, sleep problems, cardiovascular history, and previous responses to other medicines before choosing it.
The medicine should not be started, stopped, or combined with another antidepressant solely because anxiety symptoms change from one day to the next.
Childhood Nocturnal Enuresis
Specialist clinicians may use imipramine for nocturnal enuresis, meaning repeated bed-wetting during sleep. Children need assessment for urinary symptoms, constipation, sleep disorders, diabetes, emotional stress, and other medical causes before treatment is selected.
Children are especially vulnerable to serious harm from an overdose. Tofranil must remain secured away from children, including younger siblings who may mistake tablets for sweets.
Comparison
Tofranil contains imipramine. Tryptizol contains amitriptyline, another tricyclic antidepressant. They share some pharmacological features but are not interchangeable.
| Medicine | Active ingredient and class | Practical distinction |
|---|---|---|
| Tofranil | Imipramine; tricyclic antidepressant | Used for selected depressive and specialist indications |
| Tryptizol | Amitriptyline; tricyclic antidepressant | Often selected for different clinical purposes, including some pain-related uses |
| Other antidepressant classes | Varies by medicine | May have different sedation, anticholinergic, seizure, and cardiac profiles |
Imipramine and amitriptyline can both cause dry mouth, constipation, blurred vision, dizziness, sedation, and cardiovascular effects. One may be preferred over the other because of the diagnosis, previous response, sleep pattern, pain symptoms, heart history, or interaction profile.
Switching from Tofranil to Tryptizol requires a planned regimen. Combining them without supervision can increase anticholinergic toxicity, sedation, seizure risk, and heart-rhythm risk.
Common mistakes
Several practical mistakes can reduce benefit or increase risk:
- Stopping Tofranil suddenly after feeling better
- Doubling a dose after forgetting one
- Mixing the medicine with alcohol
- Driving before knowing whether dizziness or sleepiness occurs
- Sharing pills with a family member who has similar symptoms
- Assuming a different-looking imipramine pill has the same strength
- Taking sedating antihistamines without checking interactions
- Ignoring persistent constipation or urinary difficulty
- Leaving pills in an accessible place
- Changing from Tofranil to Tryptizol without a tapering or switching plan
Storage should be cool, dry, and away from moisture, children, and visitors. A bathroom cabinet may expose medicines to repeated humidity, so another secure location is often more suitable.
What doctors say
In clinical practice, doctors usually view Tofranil as a medicine with established benefits and a narrower safety margin than many newer antidepressants. Its potential value must be weighed against anticholinergic effects, sedation, cardiovascular effects, and the danger of overdose.
A clinician may ask about fainting, palpitations, constipation, urinary symptoms, glaucoma, seizures, bipolar symptoms, alcohol use, and every current medicine. Blood pressure and mental state may be reviewed during treatment. An electrocardiogram can be considered when cardiac risk factors are present.
The first improvement may be better sleep or reduced physical tension rather than a clear lift in mood. Some patients feel sedated or dizzy before noticing antidepressant benefit. That early mismatch is a reason to report problems, not to increase the dose independently.
Common questions
How long does one dose of Tofranil keep working?
A single dose can influence the nervous system for many hours, while the antidepressant benefit develops over a longer period. The FDA prescribing information reviewed in 2021 describes imipramine as a medicine requiring scheduled dosing rather than occasional use for depression. The exact duration varies with formulation, metabolism, age, liver function, and other medicines. Do not repeat a dose early because symptoms return during the day. A prescriber can adjust the schedule when adverse effects occur.
Which habits support or hinder the response to Tofranil?
Regular sleep, consistent dosing, moderate physical activity, and avoiding alcohol can support treatment. Alcohol and other sedating substances may worsen dizziness, sleepiness, and impaired coordination. WHO guidance published in 2023 supports combining appropriate treatment with attention to daily functioning, sleep, and substance use. Keep the dosing routine stable and report persistent insomnia, agitation, or worsening mood.
Can Tofranil cause dry mouth?
Yes, dry mouth is a recognised anticholinergic effect of imipramine. FDA prescribing information from 2021 identifies anticholinergic reactions among the adverse effects requiring attention. Water, sugar-free gum, and good dental care may help, while severe dryness, mouth sores, difficulty swallowing, or persistent dental problems require clinical review. Do not add another medicine for dry mouth without checking for interactions.
Can Tofranil pills be split, crushed, or chewed?
Do not split, crush, or chew Tofranil pills unless the prescriber or dispensing instructions specifically allow it. Tablet design and strength affect how much imipramine is delivered, and changing the tablet can make the dose inaccurate. The EMA’s antidepressant guidance available in 2018 supports careful attention to formulation and dose changes during treatment. Ask for an appropriate strength or formulation rather than altering pills yourself.
Which condition rules Tofranil out?
A serious cardiac rhythm disorder, recent heart attack, narrow-angle glaucoma, urinary retention, or use of a monoamine oxidase inhibitor may rule out Tofranil or require specialist management. The FDA prescribing information reviewed in 2021 lists important cardiac, interaction, and anticholinergic precautions for imipramine. Current suicidal intent or mania also requires urgent mental-health assessment before treatment decisions. A clinician should review the full medical history before prescribing.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- U.S. Food and Drug Administration (2021). Tofranil (imipramine hydrochloride) Prescribing Information.
- National Institute for Health and Care Excellence (2022). Depression in adults: treatment and management. NICE guideline NG222.